European Society of Cardiology


Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe
 

Session Details

Poster Session 2: Lipids, Atherosclerosis - Reviewers: J.L. Johnson , R. Krams
31 Mar 09:00 - 18:00 Atherosclerosis Poster Session Poster Area - Poster Area
Chairpersons: F Di Lisa (Padua, IT), J G R De Mey (Maastricht, NL), LJ De Windt (Maastricht, NL), P Kohl (London, GB), M Giacca (Trieste, IT), M Mercola (La Jolla, US), T Padro (Barcelona, ES), O Bergmann (Stockholm, SE), J Nilsson (Malmo, SE), J van der Velden (Amsterdam, NL), K Wouters (Maastricht, NL), A J G Horrevoets (Amsterdam, NL), T H Schindler (Geneve 14, CH), M N Sheppard (London, GB), M Mayr (London, GB), R Krams (London, GB), M Gautel (London, GB), B Casadei (Oxford, GB), J L Johnson (Bristol, GB), J D Pearson (London, GB), C Terracciano (Harefield, GB), N Smart (London, GB), S Nourshargh (London, GB), M Avkiran (London, GB), S Potteaux (Paris, FR), S Hatem (Paris, FR), A R Pries (Berlin, DE), T Unger (Berlin, DE), D Hilfiker-Kleiner (Hannover, DE), F Quaini (Parma, IT), C Poggesi (Firenze, IT), P F Davies (Philadelphia, US), B C Knollmann (Nashville, US)

Presentations list

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
09:00P383A novel bioisoster of flavonoids attenuates cytokine-induced endothelial dysfunction and promotes cell proliferationS Del Turco (Pisa, IT)
09:00P385Correlation between microalbuminuria and arterial wall stiffness is more obvious in patients with never-treated type 2 diabetes than in patients with never-treated essential hypertensionD I Shin (Incheon, KR)
09:00P386The long-term cardiac mortality and the rate of percutaneous coronary intervention in patients with vasospastic anginaD I Shin (Incheon, KR)
09:00P387Secretome modulation by high-cholesterol diet in pig coronary arteriesS Rocchiccioli (Pisa, IT)
09:00P388Enhanced endocannabinoid anandamide levels improve vasodilation in atherosclerosis-prone mice: evidence for endothelium-dependent mechanismD Michel-Monigadon (Geneve, CH)
09:00P389The metalloproteinase ADAMTS-5 is present in the vasculature and its expression is related to proteoglycan turnover and lipoprotein retention in atherosclerosisA Didangelos (London, GB)
09:00P390Uric acid in patients after myocardial infarction: cross-sectional relationship between metabolic profile, subclinical inflammation and heart remodelingS Lypovetska (Ternopil, UA)
09:00P391Fractalkine (CX3CL1) in patients with stable coronary artery disease (CAD) with and without diabetes mellitusI U Njerve (Oslo, NO)
09:00P392High levels of OX40 and 4-1BB in CD4+CD28null T-cells identify a group of patients with coronary atherosclerosis that could benefit from targeted modulation of costimulatory pathwaysI E Dumitriu (London, GB)
09:00P393Uncontrolled immune response in acute myocardial infarction, dynamic changes and their relation with the severity of infarct.MJ Forteza (Valencia, ES)
09:00P394Phenotypic characterization of leukocytes at the culprit lesion site in patients with acute coronary syndromesA Mangold (Vienna, AT)
09:00P395Fluctuate in distribution of lipoprotein particle size during the early statin therapy after primary percutaneous coronary intervention for myocardial infarction with ST-segment elevationT Koizumi (Saitama, JP)
09:00P396Heptral (Ademetionine) and simvastatin in patients with nonalcoholic fatty liver disease and metabolic syndromeON Korneeva (Moscow, RU)
09:00P397Sims imaging mass spectrometry for direct heart tissue analysis :a new frontier for molecular histology